2013 annual financial data

Aptevo Therapeutics 2013 Financial results

Direct answer

Revenue was 170,000 USD.

Operating income was -53,355,000 USD and net income was -53,337,000 USD.
Operating cash flow was -51,392,000 USD.

Get free Aptevo Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
170,000 USD
Operating income
-53,355,000 USD
Net income
-53,337,000 USD
Operating cash flow
-51,392,000 USD